Citi Releases Latest Top Buy Recommendations for H Shares
In its latest research update, global financial institution Citi has published its list of top buy recommendations for Hong Kong-listed H shares. This selection highlights key stocks that Citi believes present attractive investment opportunities based on current market analysis.
Below is a summary of Citi’s latest top picks among H shares, along with their respective target prices (TPs):
-
Tencent Holdings (00700.HK): Target Price HKD 763
Tencent, a leading technology conglomerate, has been marked with strong positive momentum. On the day of the report, the stock price increased by HKD 12.40, or 2.736%, reflecting investor confidence. Short selling activity stood at approximately HKD 2.83 billion, with a short selling ratio of 17.049%. -
AIA Group (01299.HK): Target Price HKD 103
The insurance giant AIA Group saw a slight price decline of HKD 0.75, or 1.056%, in the same period. Short selling amounted to HKD 795.19 million, with an 18.541% short selling ratio. -
Hengrui Medicine (01276.HK): Target Price HKD 134
Hengrui Pharma recorded a price gain of HKD 0.95, or 1.796%, alongside a relatively modest short selling volume of HKD 23.25 million and a short ratio of 16.272%. -
MMG Limited (01208.HK): Target Price HKD 11.2
The mining company MMG saw a price decrease of HKD 0.16, or 1.935%, with short selling totaling HKD 64.49 million and a short ratio of 18.479%. -
Trip.com Group Limited (TCOM.US): Target Price USD 82
Trip.com, a major online travel service provider listed in the US, also features among the favored stocks according to Citi’s research. -
China International Capital Corporation (CICC) (03908.HK): Target Price HKD 27.66
CICC experienced a price rise of HKD 0.17, or 0.898%, with short selling recorded at HKD 16.23 million and a ratio of 8.058%. -
Montage Technology (06809.HK): Target Price HKD 305
Montage Tech witnessed a price decline of HKD 15.20, or 4.218%, amid short selling of HKD 86.31 million and a short ratio of 9.628%. -
ASM Pacific Technology (00522.HK): Target Price HKD 180
ASMPT saw the stock price drop by HKD 9.30, or 5.019%, with short selling totaling HKD 84.85 million and an 8.271% short ratio.
The data, reflecting market conditions as of June 10, 2026, includes real-time price movements and short selling statistics, providing investors with a comprehensive overview to aid decision-making.
Market Context and Implications
Citi’s research update comes at a time when Hong Kong’s financial markets are experiencing significant fluctuations, driven partly by policy changes in China, ongoing economic developments, and investor reactions to sector-specific news. The inclusion of technology giants such as Tencent and health care leaders like Hengrui Pharma in the top buy list underscores confidence in these sectors’ growth potential.
Moreover, short selling activity indicates varying degrees of market sentiment, which investors should consider alongside the target prices and fundamental company prospects.
Additional Information
Investors interested in detailed statistics, historical data, and broader market analysis can access further information through AASTOCKS and other financial news platforms, which provide real-time trading quotes, technical analysis, and market commentary.
Please note that prices for Hong Kong stocks are subject to at least a 15-minute delay in reporting, and short selling data is updated regularly during trading hours.
This summary was compiled based on the latest market research and stock recommendations issued by Citi, as published by AASTOCKS Financial News.